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The Effect of Psyllium Hydrocolloid
and Cholestyramine on Hepatic
Bile Lipid Composition in Man
W . T. Beher, PhD,* B. M . Schuman, M D * * , M . A. Block, M D , * * ^
G.J. Lin, M S , * and K. K. Casazza, BS*

The effects of a mucoid - psyllium hydrocolloid - and an anion exchange polymercholestryamine - on the total cholesterol,
total phospholipid, total bile salt, cholate,
chenodeoxycholate, and deoxycholate concentrations of hepatic bile were determined
in six post-cholecystectomy patients. Bile was
obtained by drainage through an indwelling
T-tube, which was clamped except during
bile collection. Psyllium hydrocolloid treatment (12 gm/day) for 6 to 29 days had little
or no effect on the cholesterol
or
phospholipid concentration of hepatic bile,
but increased the total bile salt pool by
gradually increasing the concentration of
deoxycholate. Cholestyramine treatment (12
gm/day) for 8 to 12 days had no significant
effect on cholesterol, phospholipid or total
bile salt concentrations. There was a significant increase in the tri- to di-hydroxy bile salt
ratio due to decreases in chenodeoxycholate
and deoxycholate concentrations. The ratio
of taurine to glycine conjugates decreased
because of reductions in concentrations of
taurine conjugates and
compensating
increases in glycine conjugates. The influence of these changes on bile micelle stability and cholesterol solubility is discussed. It
is concluded that the changes effected by
psyllium hydrocolloid may result in more
stable bile micelles and greater cholesterol
solubility. No definite conclusions can be
reached with respect to cholestyramine's
effects.
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Research.
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\A^ORLD-WIDE epidemiological surveys have generated statistical evidence
which suggests that there is a positive
correlation between blood cholesterol
concentration and the incidence of
atherosclerotic heart disease. These findings have resulted in major efforts to
develop hypocholesterolemic drugs
which would presumably lessen the tendency to develop atherosclerosis. Two
classes of effective drugs have resulted:
(a) substances that inhibit or retard the
rate of hepatic cholesterol synthesis,
and (b) drugs that increase the rate of
tissue cholesterol elimination via either
the fecal neutral steroid or bile acid
pathway. Substances of the latter type
increase the rate of cholesterol elimination in certain species, including man,
to such an extent that hepatic synthesis
of new cholesterol molecules is unable
to compensate for the loss, and a reduction of blood cholesterol concentration
results.

alter biliary micellar lipid ratios, this
may not be the case since the excretion
of bile cholesterol, phospholipids and
bile salts seems to be more or less interdependent. Thus, studies have shown
that the rates of biliary cholesterol and
phospholipid excretion depend on the
concentration of bile salts in the
enterohepatic circulation.^^-^" It is therefore apparent that the ratio of micellar
components could remain constant in
spite of a drop in biliary bile salt concentrations. Such interdependence, of
course, does not preclude the possibility of changes in the composition of the
biliary bile salt pool which could affect
cholesterol solubility. In view of the
uncertainty regarding these interrelationships, it was of interest to determine the effects of a hydrophilic
mucoid and an anion exchange resin on
the composition of bile lipids.
In the following study, we determined what changes, if any, administration of the anion exchange resin,
cholestyramine, or the hydrophilic
mucoid, psyllium hydrocolloid, induced
in
the
ratio of cholesterol:
phospholipids: bile salts and in the bile
salt composition of human hepatic bile.

Two types of drugs have been found
that primarily increase tissue cholesterol
elimination via the fecal bile acid
pathway. They are the anion exchange
polymers^-" and the hydrophilic
mucoids.'-'^ Since these drugs greatly
increase the rate of elimination of bile
salts from their enterohepatic circulating pool, ^'''^ it is possible that they also
change the size and composition of this
pool. Such changes could affect the solubility of cholesterol in bile, since this
sterol is held in solution in mixed
micelles containing definite ratios of
cholesterol, phospholipids and bile
salts.'-" The stability of bile micelles is of
interest because changes in micelle
composition, which affect cholesterol
solubility, could trigger gallstone formation or dissolution."-"

Protocol

The subjects of this experiment were
six post-cholecystectomy patients with
normal liver function. Short-arm, T-tube
catheters were placed in the common
bile duct, and were clamped continuously except during bile collections,
which were begun at least three days
prior to the start of the experimental
control period.
When the patients were in a convalescent phase, they were placed on a
standard 1500 calorie diet containing 77
gm protein, 138 gm carbohydrate and 70
gm fat. Starting with the second day on

While it might seem reasonable to
expect the increased rate of elimination
of bile salts effected by the hydrophilic
mucoids or anion exchange resins to
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Table
EFFECT OF PSYLLIUM HYDROCOLLOID ON HEPATIC BILE LIPID COMPOSITION
(All values in mmoles/liter bile)
Patient

Days on
Control or Cholestreatment* terol

Total
Phospho- Cholic
lipids
acid

BILE ACIDSt
Chenode- Deoxy- Total
B.A.
oxychollc cholic

RATIO
Cholesterol:
Phospholipid:
Total Bile Acid

1. (f)t
Control

6

2.65
± 0.77

6.18
± 1.96

10.88
± 2.27

7.70
± 2.14

1.54
± 1.99

20.1
± 3.8

1 : 2.35 :
± 0.31

7.60
± 2.60

Treated

6

4.81
± 0.96

7.41
± 1.32

9.28
I 2.54

8.41
± 2.49

5.26
± 3.23

22.9
±7.37

1 : 1.54 :
± 0.44

4.76
± 2.29

2. (f)
Control

3

2.60
± 0.46

3.70
± 0.88

15.1
± 4.3

19.6
± 4.6

5.81
± 3.07

40.5
± 6.4

1 : 1.42 :
± 0.37

15.6
± 2.2

Treated

8

2.48
± 0.33

4.29
± 0.50

12.6
± 3.4

19,1
± 2.6

10 3
± 4.5

42.0
± 5.7

1 : 1.73 :
± 0.19

16.9
± 2.4

3. (m)
Control

6

1.30
± 0.35

7.17
± 1.13

11.2
± 2.80

14.3
± 1.32

2.41
± 0.16

27.9
± 3.58

1 : 5.52 :
± 0.80

21.4
± 7.49

29

1.35
± 0.49

7.89
± 1.57

11.0
± 2.41

14.4
± 3.40

10.9
± 5.19

36.4
± 7.46

1 : 5.85 :
± 1.45

27.0
± 7.08

Treated*'

•Bile collected in A.M. and P.M. on second day and alternate days of control or treatment period. Therefore number of collections is equal to number of days in these periods. Values given are averages for the collected samples ± the Standard
Deviation. Subjects received 3 gm psyllium hydrocolloid four times a day during treatment period.
tPresent in bile as glycine and taurine conjugated bile salts.
*Sex
•"Bile collections made on the 2nd, 4th, 6th, 8th, 13th, 15th, 20th, 22nd, 27th, and 29th days.

taken from one collection on each
patient and cultured for bacteria.

this diet, 10-20 ml bile collections were
taken after breakfast and lunch every
other day. Six to eight samples were
collected from each patient during the
control period. Following this period, 3
gm of psyllium hydrocolloid''' was
administered to three patients four
times daily, before meals and at bed
time. Four grams of cholestyramine*
was given to the other three patients,
three times daily. Bile collections were
continued on alternate days during drug
administration. An aliquot of bile was

Assay M e t h o d s

Bile was assayed for bile salts,
phospholipids, and cholesterol. Following collection, duplicate samples of bile
were dried by lyophilization, and the
residues extracted with chloroform:
methanol, 2:1 (v/v). Aliquots of these
extracts, which contained the bile
lipids, were used to determine total
phospholipids^^ and conjugated bile
salts. Second aliquots were used for
determination of cholesterol and the
free bile acids, which resulted from
hydrolysis of conjugated bile salts. For
these assays, the aliquots were
evaporated to dryness, and then heated
with 7 N sodium hydroxide at 15 lbs pressure (autoclave) to hydrolyze bile acid
conjugates and cholesterol esters. The

tCenerous gift of Fellows-Testagar Division
of Fellows Medical Manufacturing Company.
^Marketed by Merck Sharp & Dohme, Division of Merck & Company Inc., under the
trade name of Cuemid.
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Table II
EFFECT OF CHOLESTYRAMINE ON HEPATIC BILE LIPID COMPOSITION
(All values in mmoles/liter bile)
Patient

4. (f)*
Control

Days on
Total
Control or Choles - Phospho- Cholic
Treatment^ terol
lipids
acid

BiLE ACiDSt
Chenode- Deoxyoxycholic cholic

Total
B.A.

RATIO
Choiesteroi:
Phospholipid:
Total Bile Acid

6

3.62
± 0.48

6.90
± 1.17

35.2
± 7.18

22.6
± 4.98

0.0

58.0
± 8,22

1 ; 1.91 :
± 0.34

16.02
± 3.16

9

4.24
± 0.83

6.81
± 1.55

35.7
± 5.64

10.3
± 3.75

0.0

45.9
± 7.90

1

1.61 :
± 0.41

10.82
± 4.12

5. (f)
Control

6

3.79
+ 0.55

6.37
± 1.66

25.7
± 7.69

16.1
± 5.18

S3
± 4.42

47.1
± 14.3

1

1.68 :
± 0.26

12.32
± 5.35

Treated

8

3.44
± 0.49

5.97
± 1.31

29.4
± 5.41

7.25
± 1.77

0,0

36.7
± 6.82

1

1.74 :
± 0.27

10.67
± 3.84

6

2.17
± 0.24

0-90
± 0.26

6.98
± 1.16

3.20
± 1.17

11.9
± 3.05

1

0.39 :
± 0.09

5.16
± 0.71

1.89
± 0.56

0.35
± 0.19

7.16
± 1.18

1.45
± 0.58

8.90
± 2.31

1 0.18 :
± 0.07

4.97
± 1.09

Treated^^

6. (f)
Control

Treated

12

± 1.17
00

•Bile collected in A.M. and P.M. on second day and alternate days of control or treatment period. Therefore number of collections is equal to number of days in these periods. Values given are averages for the collected samples ± the Standard
Deviation. Subjects received 4 gm cholestyramine three times daily during treatment period.
tPresent in bile as glycine and taurine conjugated bile salts.
•Sex
••Bile collections made on the 2nd, 4th, 6th, 8th, and 9th days.

alkaline hydrolysates were extracted
with petroleum ether to recover the
non-saponifiable material which contains cholesterol. Cholesterol was determined according to Sperry and Webb.^''

with appropriate standard solutions,
were spotted on the activated plates.
Plates spotted with conjugated bile
acids were developed with toluene:glacial acetic acid:water (7.5:12.5:1.0,
v/v). To determine cholic acid, plates
spotted with free bile acids were
developed with ethyl acetate:glacial
acetic acid (96:4, v/v). Other plates
spotted with free bile acids were
developed with ethyl acetate: 2,2,4trimethylpentane:glacial acetic acid
(10:10:2, v/v) to assay chenodeoxycholic
and/or deoxycholic acid. Following
development, the plates were air dried
and then sprayed to saturation with
ethanolic phosphomolybdic acid (20%,
wt/v). The sprayed plates were heated
for 15 minutes at 100" C to effect color
development. The concentrations of
bile acids on the plates were then determined by scanning densitometry.^''^^

The alkaline residues were acidified,
and extracted with petroleum ether to
remove fatty acids. The acidic residues
were exhaustively extracted with ethyl
ether to recover the "acidic fraction"
containing free bile acids.
Free and conjugated bile acids were
separated and determined as follows:
Thin-layer chromatographic plates were
prepared by coating 20 by 20 cm glass
plates with uniform 200 p. layers of Silica
Gel C. After air drying, the plates were
activated for two hours at 100" C.
Aliquots of extracts containing either
free or conjugated bile acids, together
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TABLE III
EFFECT OF CHOLESTYRAMINE ON THE CONCENTRATION
OF THE CONJUGATED BILE SALTS OF HEPATIC BILE
(All values In mmoles/liter bile)

Patient

Days on
Control or
Treat mont^

BILE SALTS
Glycochenodeoxycholate
+ Glycodeoxychoiate

Giycocholate

Taurocholate

Taurochenodeoxychoiate
+ Taurodeoxycholate

Total
Bile Salt
Conjugates

6.
Control

6

3.18
± 0.84

2.25
± 1.14

3.79
± 0.78

1.36
± 0.50

10.58

Treated

12

4.35
± 0.85

0.82
± 0.35

3.04
± 0.84

0.28
± 0.37

8.49

•Bile collected in A.M. and P.M. on second day and alternate days of control or treatment period. Therefore number of collections is equal to number of days in these periods. Values given are averages for the collected samples ± the Standard
Deviation. Subjects received 4 gm cholestyramine three times daily during treatment period.

Results

in the bile of any of the patients. In each
case, however, the deoxycholate concentration increased significantly (P <
.01). Since the per cent change was
minor in the hepatic bile of Patients 1
and 2, this increase had only a small
effect on the bile lipid ratio and the
total bile acid concentration. However,
in Patient 3, the percentage increase
was larger and resulted in a significant
(P < .01) change in the ratio of the bile
lipids and a decided increase in the total
bile salt concentration. Since Patient 3
was treated with psyllium hydrocolloid
for a much longer period than Patients
1 an 2 and the deoxycholate concentration increased with treatment time in
all three patients, long-term mucoid
treatment could consistently result in an
increased total biliary bile salt concentration and a changed bile salt composition. This possibility must be verified by further long-term experiments.

Tables I and II show concentrations of
total cholesterol, total phospholipids,
and the various bile salts, as well as the
ratios of these lipids, in hepatic bile
from six patients. The control data
demonstrate that the composition of
hepatic bile varied from patient to
patient. However, for each individual
patient's collections the variations in the
lipid concentrations were relatively
small, as shown by the standard deviations.
Data pertaining to the effects of psyllium hydrocolloid on the hepatic bile
lipids of three human subjects are
shown in Table I. In Patient No. 1, there
was a significant increase (P <.01) in the
bile cholesterol concentration. This was
reflected by a change in the ratio of the
bile lipids. Since, however, there was
no increase in bile cholesterol concentrations in Patients 2 and 3, it may be that
the change in Patient 1 was unrelated to
psyllium hydrocolloid treatment.

Table II shows the effects of cholestyramine on the bile lipid concentrations in three patients. There were no
changes in the concentrations of bile
cholesterol or cholate in any of the
subjects treated with cholestyramine.
There was a small but significant (P <

No significant changes in total
phospholipid, cholate or chenodeoxycholate concentrations were observed
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effected by psyllium hydrocolloid might
result in less lithogenic bile, the relationship of bile micelle stability to deoxycholate (a dihydroxy bile salt) concentration has not been defined. It has, in
fact, been theorized that micelles made
up of cholestrol, lecithin and dihydroxy bile salts may be less stable than
those made up with trihydroxy bile salts.
"'^* This theory is based on the concept that micelles containing the dihydroxy salts are larger and have less surface charge than those containing
trihydroxy bile salts. On the other hand,
increases in biliary chenodeoxycholate
(also a dihydroxy bile salt) concentration have been shown to actually effect
the dissolution of gallstones."'^'*

.01) decrease in the bile phospholipid in
Patient 6; and deoxycholate was
eliminated from the biliary bile salt
pool in Patients 5 and 6. Cholestyramine
treatment resulted in a decided
decrease (P < .001) in the concentration
of bile chenodeoxycholate in all three
patients. As a result of the changes in
bile salt composition, there was a tendency for the total bile salt concentration to decrease. Since deviations from
patient to patient were rather large, it is
difficult to assess the significance of this
decrease. Nevertheless the trend is
there, and confirms a similar trend
found by other investigators.^'''^"
Table III presents data on the effects
of cholestyramine on conjugated bile
salt concentrations in hepatic bile of
Patient 6. The data show that the resin
increased the concentration of
glycocholate, and decidedly decreased
the concentrations of taurocholate,
and
taurochenodeoxycholate
plus
taurodeoxycholate. While one might
have expected a compensating increase
in the glycochenodeoxycholate plus
glycodeoxycholate concentration, it
must be remembered that cholestyramine treatment eliminated deoxycholate from the hepatic bile spectrum
(Table II) of this patient.

The increased concentration of deoxycholate in the bile of psyllium
hydrocolloid-treated subjects is difficult
to explain. Deoxycholate is a secondary
bile salt produced in the distal ileum
and the large intestine by the bacterial
7Q:-dehydroxylation of cholate. It
appears in bile following intestinal
absorption, portal blood transport, and
hepatic clearance and secretion. The
fact that psyllium hydrocolloid increases
the concentration of this anion in bile
appears to argue against a bile acidsequestering role for this drug, since
one would expect a sequestrant to
lower the deoxycholate concentration
by interrupting absorption of this intestinally synthesized bile acid. Nevertheless it has been shown that the mucoid
does increase bile acid excretion in
man' and decreases the half-life of
cholate in the bile acid pool of rats.^ It
would therefore seem that either psyllium hydrocolloid is an ineffective binding agent for deoxycholate or that there
is an increase in deoxycholate production which exceeds the ability of the
mucoid to remove it. Increased production of deoxycholate could result from
a change in the bacterial population of

Discussion
The increased concentration of deoxycholate in the hepatic bile of patients
treated with psyllium hydrocolloid is of
interest because it results in increases in
the size of the total biliary bile salt pool
and the ratio of total bile salts to cholesterol in hepatic bile. Increases such as
these have been shown to enhance
biliary micelle stability,*"" and to prevent gallstone formation and promote
gallstone dissolution in experimental
a n i m a l s . W h i l e this suggests that the
increased deoxycholate concentration
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the distal ileum and large intestine.
However, no studies have been made of
the effects of psyllium hydrocolloid on
intestinal bacteria.

The decrease in deoxycholic acid concentration is more easily explained. As
mentioned above, deoxycholate is a
secondary bile salt produced by
7a-dehydroxylation of cholate anions by
the intestinal flora. One would expect
the concentration of this bile salt to
drop precipitously in cholestyraminetreated subjects, since absorption of the
intestinally synthesized bile salt would
be retarded by resin. This effect of
cholestyramine contrasts with the
increased concentration of deoxycholic
acid which appears during psyllium hydrocolloid treatment.

While the data pertaining to the
effects of cholestyramine on hepatic
bile lipid concentrations were obtained
on only three subjects treated for relatively short periods, the changes
reported above have been observed by
a number of investigators, 15.20,23,27-29
and merit a rather detailed discussion.
Cholestyramine administration results
in a large increase in the trihydroxy to
dihydroxy bile salt ratio and a marked
increase in the ratio of glycine to
taurine conjugates in bile. The increase
in the former ratio is due to decreases
in the concentrations of chenodeoxycholate and deoxycholate anions.

The increase in the glycine to taurine
conjugate ratio probably stems from
exhaustion of the limited hepatic
taurine supply
and the fact that
cholestyramine preferentially sequesters taurine conjugates.The increased
rate of hepatic bile acid synthesis
effected by cholestyramine increases
the need for the limited supply of
taurine available for bile acid conjugation, and conjugation shifts to the
more readily available glycine.

The decrease in chenodeoxycholate
could be effected by at least two different mechanisms. First, because dihydroxy bile salt anions have a higher affinity for cholestyramine than trihydroxy
bile salt anions, ^"-^^ one would expect
cholestyramine to remove chenodeoxycholate ions from the bile salt pool
more rapidly than cholate ions. Since in
human subjects treated with cholestyramine the synthesis of bile acids from
cholesterol is rate-limiting, one would
then expect an increase in the ratio of
trihydroxy to dihydroxy bile salts in bile.

Although cholestyramine effects
significant changes in the di- to trihydroxy bile salt and glycine to taurine
conjugate ratios in bile, its effect on the
ratio of cholesterol/phospholipids/bile
salts, which is an important factor determining bile micelle stability, is uncertain. Our results, together with those of
some others,
suggest a decrease in
bile acid concentrations; however,
other investigators find no change.
When the data obtained in one
experiment" was plotted, using the
triangular coordinate system of Small,
Bourges and Dervichian,' there was no
indication that cholestyramine treatment led to the formation of unstable
biliary micelles. However, caution must
be used in interpreting these results
since the use of phase relationships in

A second possibility is that cholestyramine may effect a change in the rate
of bile acid synthesis at the enzyme
level. Such a change could result in an
increase in cholic acid synthesis at the
expense of chenodeoxycholic acid
synthesis.While this is an attractive
hypothesis, no change in the activity of
the
12a-hydroxylase
of
cholest4-en-7a-o1-3-one is seen in cholestryamin-treated rats.^^
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a solution as complex as bile is not infall i b l e a n d takes n o a c c o u n t o f t h e
changes in bile acid anion c o m p o s i t i o n
that result f r o m cholestyramine treatment.

efficient cholesterol solubilizers than
taurine conjugates.2°
From t h e f o r e g o i n g d i s c u s s i o n , it is
obvious that no definite conclusions as
to the effects of cholestyramine on
b i l i a r y c h o l e s t e r o l s o l u b i l i t y can be
made at this t i m e . Since this r e s i n is
used in t h e l o n g - t e r m t r e a t m e n t of
h y p e r c h o l e s t e r o l e m i a , it is o b v i o u s l y
important to devise experiments w h i c h
w i l l define more precisely the complex
i n t e r r e l a t i o n s h i p s i n v o l v e d in m i c e l l e
s t a b i l i t y , and to d e t e r m i n e t h e actual
effects of anion exchange polymers o n
their stability.

The shift t o w a r d trihydroxy bile salts
w o u l d appear t o result in m o r e stable
m i c e l l e s . " ' " H o w e v e r , s t u d i e s have
shown that bile rich in chenodeoxycholate effects dissolution of galls t o n e s . ^ ^ ' " The shift in t h e g l y c i n e t o
taurine conjugate ratio w o u l d appear to
result in more stable bile micelles, since
glycine c o n j u g a t e s appear to be m o r e
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